← Back to patent-cliff list
Bupivacaine
Tier C — Watch / tradeBupivacaine
Cellix Bio Pvt Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Sodium channels
Brand：BupiZenge
Indications (approved)：肩峰撞击综合征、术后疼痛
Regional status
US
批准上市
EU
临床三期
2026-07-07
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bupivacaine?
Approved indications include: 肩峰撞击综合征, 术后疼痛.
When does the Bupivacaine patent expire?
No public expiry year is available for Bupivacaine yet; this page updates once verified.
How do I get a quote for Bupivacaine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25